Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Transcenta Holding Limited Board/Management Information 2021

Sep 28, 2021

51014_rns_2021-09-27_3f79bc23-7f65-4084-8786-d6e4ab7ae999.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [137 x 41] intentionally omitted <==

Transcenta Holding Limited 創勝集團醫藥有限公司

(registered by way of continuation in the Cayman Islands with limited liability)

(Stock Code: 6628)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the “ Board ”) of Transcenta Holding Limited (the “ Company ”) are set out below.

Executive directors

Dr. Xueming Qian (錢雪明) (Chief Executive Officer)

Dr. Michael Ming Shi (石明)

  • Mr. Albert Da Zhu (朱達)

Non-executive director

Dr. Yining (Jonathan) Zhao (趙奕寧) (Chairman)

Independent non-executive directors

Mr. Jiasong Tang (唐稼松)

Dr. Jun Bao (包駿)

  • Mr. Zhihua Zhang (張志華)

The Board has three committees. The table below details membership of these committees.

Director Auditcommittee Remunerationcommittee Nominationcommittee
Dr. Xueming Qian (錢雪明) Member
Dr. Michael Ming Shi (石明)
Mr. Albert Da Zhu (朱達)
Dr. Yining (Jonathan) Zhao (趙奕寧) Member
Mr. Jiasong Tang (唐稼松) Chairperson Member
Dr. Jun Bao (包駿) Chairperson Member
Mr. Zhihua Zhang (張志華) Member Member Chairperson

September 28, 2021